Similar articles

• [Treatment of uremic osteopathy. Effects of vitamin D metabolites and vitamin D analogs in chronic uremia and experimental renal insufficiency].

  von Herrath D, Kraft D, Schaefer K, Krempien B. von Herrath D, et al. MMW Munch Med Wochenschr. 1974 Sep 13;116(37):1573-8. MMW Munch Med Wochenschr. 1974. PMID: 4374654 German. No abstract available.
• Calcifediol (25-hydroxyvitamin D3) in the treatment of uremic bone disease.

  Teitelbaum SL. Teitelbaum SL. Ann Intern Med. 1981 Mar;94(3):404-5. doi: 10.7326/0003-4819-94-3-404. Ann Intern Med. 1981. PMID: 6894359 No abstract available.
• Effects of 6 months therapy with 1,25 (OH)2D3 on bone disease of dialysis patients.

  Malluche HH, Goldstein DA, Massry SG. Malluche HH, et al. Contrib Nephrol. 1980;18:98-104. doi: 10.1159/000403277. Contrib Nephrol. 1980. PMID: 7353383 No abstract available.
• Short-term effects of 1,25-dihydroxycholecalciferol on disordered calcium metabolism of renal failure.

  Brickman AS, Coburn JW, Norman AW, Massry SG. Brickman AS, et al. Am J Med. 1974 Jul;57(1):28-33. doi: 10.1016/0002-9343(74)90764-5. Am J Med. 1974. PMID: 4600292 Review. No abstract available.
• The management of renal osteodystrophy.

  de Wardener HE, Eastwood JB. de Wardener HE, et al. Adv Exp Med Biol. 1977;81:533-47. doi: 10.1007/978-1-4613-4217-5_52. Adv Exp Med Biol. 1977. PMID: 331902 Review.